Eyal Neria
Plus aucun poste en cours
Profil
Eyal Neria served as Co-Chief Executive Officer at CapsuTech Ltd.
from 2011 to 2012.
He was also the Chief Executive Officer at Mitoconix Bio Ltd.
and a Director at Neviah Genomics Ltd.
In addition, he held the position of Vice President-Therapeutic Development at Compugen Ltd.
from 2010 to 2013.
Dr. Neria received his undergraduate and doctorate degrees from Tel-Aviv University.
Anciens postes connus de Eyal Neria
| Sociétés | Poste | Fin |
|---|---|---|
Mitoconix Bio Ltd.
 Mitoconix Bio Ltd. BiotechnologyHealth Technology Mitoconix Bio Ltd. develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases. The company was founded by Daria Mochly-Rosen in August 2016 and is headquartered in Ness Ziona, Israel. | Directeur Général | - |
| COMPUGEN LTD. | Directeur Technique/Scientifique/R&D | - |
Neviah Genomics Ltd.
 Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Directeur/Membre du Conseil | - |
CapsuTech Ltd.
 CapsuTech Ltd. Medical DistributorsDistribution Services CapsuTech Ltd. develops polymers for drug targeting and encapsulation. It is a product driven startup company focuses on research and development of semi-natural, peptide-based, polymers for drug targeting and encapsulation of various chemical and biological entities such as drugs, cosmetics, vitamins, food additives, proteins, virions and even cells. The company was founded by Jallal M. Gnaim in May 2006 and is headquartered in Nazareth, Israel. | Directeur Général | - |
Formation de Eyal Neria
| Tel-Aviv University | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| COMPUGEN LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
CapsuTech Ltd.
CapsuTech Ltd. Medical DistributorsDistribution Services CapsuTech Ltd. develops polymers for drug targeting and encapsulation. It is a product driven startup company focuses on research and development of semi-natural, peptide-based, polymers for drug targeting and encapsulation of various chemical and biological entities such as drugs, cosmetics, vitamins, food additives, proteins, virions and even cells. The company was founded by Jallal M. Gnaim in May 2006 and is headquartered in Nazareth, Israel. | Distribution Services |
Neviah Genomics Ltd.
Neviah Genomics Ltd. Pharmaceuticals: MajorHealth Technology Neviah Genomics Ltd. develops novel biomarkers for the prediction of drug-induced toxicity. It identifies biomarkers for the prediction of drug-induced toxicity. The firm offers involving cell harvest and culture, compound exposure, mRNA expression analysis and multi-parameter mathematical computation. The company was founded in 2012 and is headquartered in Yavne, Israel. | Health Technology |
Mitoconix Bio Ltd.
Mitoconix Bio Ltd. BiotechnologyHealth Technology Mitoconix Bio Ltd. develops novel therapeutics to improve mitochondrial health as a disease-modifying therapeutics for neurodegenerative diseases. The company was founded by Daria Mochly-Rosen in August 2016 and is headquartered in Ness Ziona, Israel. | Health Technology |
